Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Treasury Shares: 2020-2022

Historic Treasury Shares for Cullinan Therapeutics (CGEM) over the last 3 years, with Dec 2022 value amounting to $369,000.

  • Cullinan Therapeutics' Treasury Shares was N/A to $85.6 million in Q3 2023 from the same period last year, while for Sep 2023 it was $85.6 million, marking a year-over-year change of. This contributed to the annual value of $369,000 for FY2022, which is 414506.74% up from last year.
  • Latest data reveals that Cullinan Therapeutics reported Treasury Shares of $369,000 as of FY2022, which was up 414,506.74% from $89 recorded in FY2021.
  • Cullinan Therapeutics' 5-year Treasury Shares high stood at $369,000 for FY2022, and its period low was $89 during FY2021.
  • Over the past 3 years, Cullinan Therapeutics' median Treasury Shares value was $364,000 (recorded in 2020), while the average stood at $244,363.
  • Its Treasury Shares has fluctuated over the past 5 years, first slumped by 99.98% in 2021, then soared by 414,506.74% in 2022.
  • Cullinan Therapeutics' Treasury Shares (Yearly) stood at $364,000 in 2020, then plummeted by 99.98% to $89 in 2021, then soared by 414,506.74% to $369,000 in 2022.